United States · FDA National Drug Code directory
Dihydroergotamine Mesylate Nasal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-503_68a5f507-1f3a-412d-8321-1e8d74cc31bc
- Product NDC
- 69097-503
- Form
- SPRAY, METERED
- Composition / generic term
- Dihydroergotamine Mesylate Nasal
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200523
- Source listing expiry
- 20261231
Source-listed ingredients
- DIHYDROERGOTAMINE MESYLATE — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 8 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL · 69097-503-27
- 1 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL · 69097-503-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →